Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RARB | P10826 | 2/20 | 0.41 |
| ▸ | RARG | P13631 | 2/20 | 0.41 |
| ▸ | RARA | P10276 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18727653 | 0.86 | ALDH1A1 (0.43) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL10434261 | 0.85 | ALDH1A1 (0.40) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL10434262 | 0.85 | ALDH1A1 (0.40) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL3148661 | 0.83 | MEN1 (0.44) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL3233226 | 0.83 | ALDH1A1 (0.42) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL21574083 | 0.82 | MEN1 (0.46) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL10781690 | 0.82 | ALDH1A1 (0.42) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL11793969 | 0.81 | ALDH1A1 (0.41) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL20610551 | 0.81 | ALDH1A1 (0.44) | ALDH1A1GAAMAPTNPSR1TRPA1 | |
| SCHEMBL7650224 | 0.81 | ALDH1A1 (0.44) | ALDH1A1GAAMAPTNPSR1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3649184-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| EP-3649183-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| WO-2019010263-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| WO-2019010265-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-11958859-B2 | Use of pyridoxal acetal salts as water-triggered pro-fragrances | FLORIDA GULF COAST UNIVERSITY BOARD OF TRUSTEES (US) | 2024-04-16 | — | — | US | disclosed |
| EP-2775839-B1 | METHODS FOR ASSESSING REPELLANT QUALITY OF ORGANIC MATERIALS AND METHODS AND COMPOSITIONS FOR REPELLING ARTHROPODS | UNIV CALIFORNIA (US) | 2023-12-06 | — | — | EP | disclosed |
| EP-3416729-B1 | PRO-FRAGRANCE COMPOSITION | AQDOT LTD (GB) | 2023-09-20 | — | — | EP | disclosed |
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| CN-110891615-B | System and method for selecting and releasing fragrance | 阿甘香气及精细化学有限公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-108601958-B | Pro-fragrance compositions | 爱客多有限公司 | 2022-06-17 | — | — | CN | disclosed |
| US-20210053980-A1 | Use of Pyridoxal Acetal Salts as Water-Triggered Profragrances | VITACHEM LLC (US) | 2021-02-25 | — | — | US | disclosed |
| WO-2002096850-A1 | PRECURSORS FOR KETONES AND ALDEHYDES | GIVAUDAN SA (CH) | 2002-12-05 | — | — | WO | disclosed |
| EP-1262473-A1 | Precursors for fragrant ketones and fragrant aldehydes | Givaudan SA (CH) | 2002-12-04 | — | — | EP | disclosed |
| JP-2002226416-A | (-)-4-(2,6,6-TRIMETHYL-1-CYCLOHEXENYL)BUTAN-2-OL, METHOD FOR PRODUCING THE SAME AND PERFUME COMPOSITION COMPRISING THE SAME | TOYOTAMA KORYO KK | 2002-08-14 | — | — | JP | disclosed |
| JP-2002226415-A | (+)-4-(2,6,6-TRIMETHYL-1-CYCLOHEXENYL)BUTAN-2-OL, METHOD FOR PRODUCING THE SAME AND PERFUME COMPOSITION COMPRISING THE SAME | TOYOTAMA KORYO KK | 2002-08-14 | — | — | JP | disclosed |
| JP-2002226416-A | (-)-4-(2,6,6-TRIMETHYL-1-CYCLOHEXENYL)BUTAN-2-OL, METHOD FOR PRODUCING THE SAME AND PERFUME COMPOSITION COMPRISING THE SAME | TOYOTAMA KORYO KK | 2002-08-14 | — | — | JP | disclosed |
| JP-2002226415-A | (+)-4-(2,6,6-TRIMETHYL-1-CYCLOHEXENYL)BUTAN-2-OL, METHOD FOR PRODUCING THE SAME AND PERFUME COMPOSITION COMPRISING THE SAME | TOYOTAMA KORYO KK | 2002-08-14 | — | — | JP | disclosed |
| US-5464865-A | Enzyme inhibitors as antiinflammatory agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1995-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958859-B2 | Use of pyridoxal acetal salts as water-triggered pro-fragrances | PLPBP, PNPO, ADH5 | ALDH1A1 394/4885GAA 3583/4885MAPT 2016/4885 |
| US-20210053980-A1 | Use of Pyridoxal Acetal Salts as Water-Triggered Profragrances | PLPBP, PNPO, VKORC1 | ALDH1A1 389/4885GAA 3167/4885MAPT 1839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.